Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Chatham Lodging Trust is a reit-hotel & motel business based in the US. Chatham Lodging Trust shares (CLDT) are listed on the NYSE and all prices are listed in US Dollars. Chatham Lodging Trust employs 23 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$12.48|
|52-week range||$6.90 - $14.95|
|50-day moving average||$12.28|
|200-day moving average||$12.66|
|Wall St. target price||$15.80|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.58|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-1.65%|
|1 month (2021-09-23)||-0.95%|
|3 months (2021-07-23)||6.21%|
|6 months (2021-04-23)||-7.62%|
|1 year (2020-10-23)||54.26%|
|2 years (2019-10-23)||-30.12%|
|3 years (2018-10-23)||19.44|
|5 years (2016-10-21)||18|
Valuing Chatham Lodging Trust stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chatham Lodging Trust's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Chatham Lodging Trust's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.13. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Chatham Lodging Trust's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Chatham Lodging Trust's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.9 million.
The EBITDA is a measure of a Chatham Lodging Trust's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$140.3 million|
|Gross profit TTM||$37.5 million|
|Return on assets TTM||-1.79%|
|Return on equity TTM||-3.6%|
|Market capitalisation||$618.7 million|
TTM: trailing 12 months
There are currently 851,349 Chatham Lodging Trust shares held short by investors – that's known as Chatham Lodging Trust's "short interest". This figure is 17.3% down from 1.0 million last month.
There are a few different ways that this level of interest in shorting Chatham Lodging Trust shares can be evaluated.
Chatham Lodging Trust's "short interest ratio" (SIR) is the quantity of Chatham Lodging Trust shares currently shorted divided by the average quantity of Chatham Lodging Trust shares traded daily (recently around 341907.22891566). Chatham Lodging Trust's SIR currently stands at 2.49. In other words for every 100,000 Chatham Lodging Trust shares traded daily on the market, roughly 2490 shares are currently held short.
However Chatham Lodging Trust's short interest can also be evaluated against the total number of Chatham Lodging Trust shares, or, against the total number of tradable Chatham Lodging Trust shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chatham Lodging Trust's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Chatham Lodging Trust shares in existence, roughly 20 shares are currently held short) or 0.0179% of the tradable shares (for every 100,000 tradable Chatham Lodging Trust shares, roughly 18 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chatham Lodging Trust.
Find out more about how you can short Chatham Lodging Trust stock.
We're not expecting Chatham Lodging Trust to pay a dividend over the next 12 months.
Over the last 12 months, Chatham Lodging Trust's shares have ranged in value from as little as $6.9 up to $14.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Chatham Lodging Trust's is 1.9947. This would suggest that Chatham Lodging Trust's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Chatham Lodging Trust is a self-advised, publicly traded real estate investment trust focused primarily on investing in upscale, extended-stay hotels and premium-branded, select-service hotels. At September, 30, 2020, The company owns interests in 86 hotels totaling 12,040 rooms/suites, comprised of 40 properties it wholly owns with an aggregate of 6,092 rooms/suites in 15 states and the District of Columbia and a minority investment in the Innkeepers joint ventures that owns 46 hotels with an aggregate of 5,948 rooms/suites. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.